Last week, herd immunity was questionable and neither Hydroxychloroquine nor Remdesivir were looking good. Today, the reverse. Everyone who said we should use data to make decisions has to tell us which week the data is accurate. Are we good yet?
Without seeing the raw data the effect size seems impressive. Ideally a "trend" towards mortality benefit means a bigger trial might show us that result.. unfortunately now it will be hard and possibly deemed (by pharma) "unethical" to enroll pts in such trials
-
-
I think we still have full trial set data coming after whatever gets released today - enrollment only closed 9 days ago. Trials in Europe have enrolled massive numbers. This will probably be useful:https://clinicaltrials.gov/ct2/show/NCT04315948 …
-
Am I reading this wrong or are they not using the HCQ combined with z-pack and zinc? And this appears to be studying only the most severe cases. Why? IMHO, we should find something like the HCQ combo to give at early stage to prevent complications, including mortality.

- 1 more reply
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.